250 related articles for article (PubMed ID: 14555520)
1. Gene-specific formation and repair of DNA monoadducts and interstrand cross-links after therapeutic exposure to nitrogen mustards.
Souliotis VL; Dimopoulos MA; Sfikakis PP
Clin Cancer Res; 2003 Oct; 9(12):4465-74. PubMed ID: 14555520
[TBL] [Abstract][Full Text] [Related]
2. Extent of damage and repair in the p53 tumor-suppressor gene after treatment of myeloma patients with high-dose melphalan and autologous blood stem-cell transplantation is individualized and may predict clinical outcome.
Dimopoulos MA; Souliotis VL; Anagnostopoulos A; Papadimitriou C; Sfikakis PP
J Clin Oncol; 2005 Jul; 23(19):4381-9. PubMed ID: 15883412
[TBL] [Abstract][Full Text] [Related]
3. Preferential in vivo DNA repair of melphalan-induced damage in human genes is greatly affected by the local chromatin structure.
Souliotis VL; Dimopoulos MA; Episkopou HG; Kyrtopoulos SA; Sfikakis PP
DNA Repair (Amst); 2006 Aug; 5(8):972-85. PubMed ID: 16781199
[TBL] [Abstract][Full Text] [Related]
4. Melphalan-induced DNA damage in vitro as a predictor for clinical outcome in multiple myeloma.
Dimopoulos MA; Souliotis VL; Anagnostopoulos A; Bamia C; Pouli A; Baltadakis I; Terpos E; Kyrtopoulos SA; Sfikakis PP
Haematologica; 2007 Nov; 92(11):1505-12. PubMed ID: 18024399
[TBL] [Abstract][Full Text] [Related]
5. Association between transcriptional activity, local chromatin structure, and the efficiencies of both subpathways of nucleotide excision repair of melphalan adducts.
Episkopou H; Kyrtopoulos SA; Sfikakis PP; Fousteri M; Dimopoulos MA; Mullenders LH; Souliotis VL
Cancer Res; 2009 May; 69(10):4424-33. PubMed ID: 19417135
[TBL] [Abstract][Full Text] [Related]
6. Melphalan-induced DNA damage in p53(+/-) and wild type mice analysed by the comet assay.
Cordelli E; Cinelli S; Lascialfari A; Ranaldi R; Pacchierotti F
Mutat Res; 2004 Jun; 550(1-2):133-43. PubMed ID: 15135647
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 affects melphalan-induced DNA damage and repair in human multiple myeloma cells.
Efferth T; Fabry U; Osieka R
Anticancer Res; 2002; 22(1A):231-4. PubMed ID: 12017294
[TBL] [Abstract][Full Text] [Related]
8. Adenine-containing DNA-DNA cross-links of antitumor nitrogen mustards.
Balcome S; Park S; Quirk Dorr DR; Hafner L; Phillips L; Tretyakova N
Chem Res Toxicol; 2004 Jul; 17(7):950-62. PubMed ID: 15257621
[TBL] [Abstract][Full Text] [Related]
9. In vivo DNA cross-linking by cyclophosphamide: comparison of human chronic lymphatic leukemia cells with mouse L1210 leukemia and normal bone marrow cells.
DeNeve W; Valeriote F; Edelstein M; Everett C; Bischoff M
Cancer Res; 1989 Jul; 49(13):3452-6. PubMed ID: 2731167
[TBL] [Abstract][Full Text] [Related]
10. Formation and removal of DNA cross-links induced by melphalan and nitrogen mustard in relation to drug-induced cytotoxicity in human melanoma cells.
Hansson J; Lewensohn R; Ringborg U; Nilsson B
Cancer Res; 1987 May; 47(10):2631-7. PubMed ID: 3567896
[TBL] [Abstract][Full Text] [Related]
11. Gene-specific DNA interstrand cross-links produced by nitrogen mustard in the human tumor cell line Colo320HSR.
Futscher BW; Pieper RO; Dalton WS; Erickson LC
Cell Growth Differ; 1992 Apr; 3(4):217-23. PubMed ID: 1515367
[TBL] [Abstract][Full Text] [Related]
12. Alkylator resistance in human B lymphoid cell lines: (1). Melphalan accumulation, cytotoxicity, interstrand-DNA-crosslinks, cell cycle analysis, and glutathione content in the melphalan-sensitive B-lymphocytic cell line (WIL2) and in the melphalan-resistant B-CLL cell line (WSU-CLL).
Pu Q; Bianchi P; Bezwoda WR
Anticancer Res; 2000; 20(4):2561-8. PubMed ID: 10953327
[TBL] [Abstract][Full Text] [Related]
13. Differences between melphalan and nitrogen mustard in the formation and removal of DNA cross-links.
Ross WE; Ewig RA; Kohn KW
Cancer Res; 1978 Jun; 38(6):1502-6. PubMed ID: 565677
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of DNA cross-linking in normal and neoplastic mouse tissues following treatment with cis-diamminedichloroplatinum(II) in vivo.
Murray D; Jenkins WT; Meyn RE
Cancer Res; 1985 Dec; 45(12 Pt 1):6446-52. PubMed ID: 4063992
[TBL] [Abstract][Full Text] [Related]
15. The repair of melphalan-induced DNA adducts in the transcribed strand of active genes is subject to a strong polarity effect.
Episkopou H; Kyrtopoulos SA; Sfikakis PP; Dimopoulos MA; Souliotis VL
Mutat Res; 2011 Sep; 714(1-2):78-87. PubMed ID: 21762707
[TBL] [Abstract][Full Text] [Related]
16. Topoisomerase II inhibition and altered kinetics of formation and repair of nitrosourea and cisplatin-induced DNA interstrand cross-links and cytotoxicity in human glioblastoma cells.
Ali-Osman F; Berger MS; Rajagopal S; Spence A; Livingston RB
Cancer Res; 1993 Dec; 53(23):5663-8. PubMed ID: 8242621
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of melphalan resistance developed in vitro in human melanoma cells.
Parsons PG; Carter FB; Morrison L; Regius Mary Sister
Cancer Res; 1981 Apr; 41(4):1525-34. PubMed ID: 6163526
[TBL] [Abstract][Full Text] [Related]
18. DNA damage in cyclophosphamide-resistant tumor cells: the role of glutathione.
Richardson ME; Siemann DW
Cancer Res; 1995 Apr; 55(8):1691-5. PubMed ID: 7712476
[TBL] [Abstract][Full Text] [Related]
19. Preferential repair incision of cross-links versus monoadducts in psoralen-damaged plasmid DNA by human cell-free extracts.
Calsou P; Sage E; Moustacchi E; Salles B
Biochemistry; 1996 Nov; 35(47):14963-9. PubMed ID: 8942662
[TBL] [Abstract][Full Text] [Related]
20. Implications of enzymatic, acidic and thermal hydrolysis of DNA on the occurrence of cross-linked melphalan DNA adducts.
Van den Driessche B; Lemière F; Witters E; Van Dongen W; Esmans EL
Rapid Commun Mass Spectrom; 2005; 19(4):449-54. PubMed ID: 15655794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
